By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems said after the close of the market on Thursday that it has closed on its $7.2 million registered direct offering.

Net proceeds from the offering totaled about $6.7 million. The amount raised includes $1 million from Chairman and CEO Alnoor Shivji and about $500,000 in aggregate from four other board members.

Proceeds will be used for general working capital purposes and continued commercialization of its SmartChip Real-Time PCR System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.